NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from NextechLabs? Mail in a sample (US only) and let us test it.

Test my supply
64%
Finnrick rating
#351 of 457 ranked vendors
23 of 32 classifiable tests passed
methodology · Purity focus
Finnrick analysis

NextechLabs' purity-focus record is product-specific, led by consistently clean Retatrutide and Ipamorelin, with Semaglutide passing on a narrow, aging batch record. BPC-157 and CJC-1295 show repeated purity misses and fill volatility, while Tirzepatide improved after early misses; multi-lab evidence helps, but same-batch clusters and missing batch IDs leave

methodology →
vendor intelligence report
Vendor Intelligence Report: NextechLabs

A Delaware filing, a formation-service address, and a Florida postal return point complicate NextechLabs' public operating story. The report also follows COA upload-path anomalies, abandoned web-build artifacts, fulfillment-location signals, and Zelle recourse.

24 pages7 risk factors assessed13 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$15.00
84%
9
2
Tirzepatide
$5.00
76%
6
3
Ipamorelin
$7.00
73%
4
4
Semaglutide
$23.00
70%
2
5
BPC-157
$7.80
45%
7
6
CJC-1295
$7.00
32%
4
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%14 Jan 2025: 60%14 Jan 2025: 34%14 Jan 2025: 53%14 Jan 2025: 59%23 Jan 2025: 59%23 Jan 2025: 59%23 Jan 2025: 60%23 Jan 2025: 60%27 Feb 2025: 59%27 Feb 2025: 62%27 Feb 2025: 57%28 Feb 2025: 53%28 Feb 2025: 53%28 Feb 2025: 54%28 Feb 2025: 54%28 Feb 2025: 53%28 Feb 2025: 53%28 Feb 2025: 54%2 Mar 2025: 60%2 Mar 2025: 61%3 Mar 2025: 59%5 Mar 2025: 60%5 Mar 2025: 60%20 Mar 2025: 60%20 Mar 2025: 60%20 Mar 2025: 60%20 Mar 2025: 60%20 Mar 2025: 60%17 Jul 2025: 59%9 Oct 2025: 60%23 Apr 2026: 60%9 Aug 2026: 60%7 Oct 2026: current 64%60%60%64%Jan 25Oct 26
Free peptide testing

Ordered peptides from NextechLabs? Mail in a sample (US only) and let us test it.

Test my supply
NextechLabs test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
9 Aug 2026
Pass
Retatrutide
lab nameView COA
23 Apr 2026
Pass
Retatrutide
lab nameView COA
9 Oct 2025
Pass
Retatrutide
lab nameView COA
17 Jul 2025
Fail
BPC-157
lab nameView COA
20 Mar 2025
Pass
Tirzepatide
lab nameView COA
20 Mar 2025
Fail
CJC-1295 (No DAC)
lab nameView COA
20 Mar 2025
Fail
BPC-157
lab nameView COA
20 Mar 2025
Pass
Ipamorelin
lab nameView COA
20 Mar 2025
Pass
Retatrutide
lab nameView COA
5 Mar 2025
Pass
Ipamorelin
lab nameView COA
1-10 of 32

About NextechLabs test results from Finnrick

NextechLabs is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 32 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible NextechLabs peptides in this dataset are BPC-157 (7 tests), CJC-1295 (4 tests) and Ipamorelin (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 32 recent tests. It also includes 1 correction related to this vendor.

Corrections
2025-04-17
Finnrick data entry
Lab A test 27 Feb 2025, lab C test 28 Feb 2025, lab B test 30 Mar 2025: updated batch claim quantity, label claim was clear, erroneously listed 10mg.
Free peptide testing

Ordered peptides from NextechLabs? Mail in a sample (US only) and let us test it.

Test my supply